April 15th 2025
Access USA converges in Philadelphia to explore new—and needed—solutions to boost patient outcomes.
Making Adjustments to Reimbursement Models Impacting Patient Therapies in the Biosimilar Space
June 24th 2024In an interview with Pharma Commerce Editor Nicholas Saraceno, Fran Gregory, PharmD, Vice President of Emerging Therapies, Cardinal Health, discusses ways that changes made to reimbursement models are affecting patient therapies in the biosimilar space.